No Chart Data Available
No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹37.3Prev. Close
₹36.5Turnover(Lac.)
₹1.04Day's High
₹37.5Day's Low
₹3452 Week's High
₹86.8552 Week's Low
₹23.2Book Value
₹2.44Face Value
₹1Mkt Cap (₹ Cr.)
164.51P/E
18.2EPS
1.91Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 4.73 | 4.73 | 4.73 | 4.73 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 5.23 | -4.4 | 0.73 | 10.16 |
Net Worth | 9.96 | 0.33 | 5.46 | 14.89 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 132.71 | 106.28 | 1.46 | 0.19 |
yoy growth (%) | 24.86 | 7,179.88 | 660 | -89 |
Raw materials | -96.85 | -80.24 | -0.35 | -0.08 |
As % of sales | 72.97 | 75.5 | 24.24 | 42.54 |
Employee costs | -14.09 | -10.8 | -0.83 | -2.13 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 5.53 | 1.22 | -1 | -4.04 |
Depreciation | -1.91 | -1.66 | -0.34 | -0.29 |
Tax paid | -0.43 | 0.15 | 0.07 | 0 |
Working capital | 5.9 | 31.91 | -0.32 | 1.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 24.86 | 7,179.88 | 660 | -89 |
Op profit growth | 88.23 | -553.78 | -70.97 | 76.22 |
EBIT growth | 137.67 | -609.74 | -78.87 | 110.41 |
Net profit growth | 269.61 | -248.57 | -77.06 | 138.02 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,845.2 | 101.44 | 4,42,725.29 | 705.44 | 0.87 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,885 | 71.05 | 1,82,775.12 | 598 | 0.43 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,484.15 | 67.95 | 1,51,764.01 | 577 | 0.13 | 2,547 | 249.82 |
Cipla Ltd CIPLA | 1,398.95 | 30.54 | 1,13,007.26 | 384.64 | 0.93 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,307.1 | 33.88 | 1,09,098.01 | -219.4 | 0.61 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / MD / CEO
Sameer Goel
Independent Non Exe. Director
Vipul Goel
Independent Non Exe. Director
Jagdeep Dhavvan
Independent Non Exe. Director
Richa Gupta
Bhondsi Village,
Tehsil Sohna,
Haryana - 122102
Tel: 91-11-29535650
Website: http://www.kimiabiosciences.com
Email: compliance.kimia@gmail.com
99 BeetalHouse 3rd F,
Behind Local Shp Cen, Nr Dada Harsukh Das,
New Delhi - 110062
Tel: 011-29961281-83
Website: www.beetalfinancial.com
Email: beetal@beetalfinancial.com
Summary
Kimia Biosciences Limited, formerly known Laurel Organics Limited was incorporated in September, 1993. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. Th...
Read More
Reports by Kimia Biosciences Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.